Status:
COMPLETED
Understanding Value in Metastatic Breast Cancer
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
Genentech, Inc.
Conditions:
Metastatic Breast Cancer
Eligibility:
FEMALE
18-90 years
Brief Summary
The overall objective of this project is to gain knowledge about out-of-pocket (OOP) expenses and lost opportunity costs among metastatic breast cancer (MBC) patients. To achieve this objective, MBC p...
Detailed Description
The treating physician, PI or study coordinator will inform eligible MBC patients about the study via a letter (Appendix B) during or prior to their regular clinic visits in a waiting area. Prior to t...
Eligibility Criteria
Inclusion
- All female MBC patients 18 years of age and older who have received treatment within the past two years at UAB
Exclusion
- Non-English speakers, patients residing in nursing homes or receiving hospice care
Key Trial Info
Start Date :
June 13 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 12 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03257917
Start Date
June 13 2017
End Date
July 12 2019
Last Update
August 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35249